Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
03/2002
03/07/2002CA2383855A1 Dyes for keratin fibers, the dyes containing n-benzyl-p-phenylenediamine derivatives and novel n-benzyl-p-phenylenediamine derivatives
03/06/2002EP1183229A1 Glucagon antagonists/inverse agonists
03/06/2002EP0883403A4 Method for treating sexual dysfunctions
03/06/2002CN1339032A Reverse hydroxamate inhibitors of matrix metalloproteinases
03/06/2002CN1080263C Method and compositions for the synthesis of dioxolane nucleosides with 'beta'-configuration
03/06/2002CN1080251C Dihalopropene compound, insecticide/acaricide containing said dihalopropene compound as active ingredient and intermediate compound for use inproduct of said dihalopropene compounds
03/05/2002US6353099 Substituted ureas as cell adhesion inhibitors
03/05/2002CA2207574C Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
03/05/2002CA2126465C Inhibitor for restenosis after percutaneous coronary arterioplasty
02/2002
02/28/2002WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
02/28/2002WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/28/2002WO2002016316A1 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE
02/28/2002WO2002016315A1 Aza-amino acid derivatives (factor xa-inhibitors 15)
02/28/2002WO2001070720A3 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
02/28/2002WO2001068593A3 Amino acid derivatives as hiv aspartyl protease inhibitors
02/28/2002WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
02/28/2002US20020026065 2-hydroxy-3 - (4-hydroxy-3-sulfonamidophenyl) - propylamines useful as beta 3 adrenergic agonists
02/28/2002CA2420289A1 10-aryl-11-hbenzo [b]fluorene derivatives and analogs for medicinal use
02/28/2002CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/28/2002CA2415838A1 Aza-amino acid derivatives (factor xa-inhibitors 15)
02/27/2002EP1182201A1 4-Methylene-1,3-dioxolanes as cross-linking agents
02/27/2002EP1181267A1 Halogen compounds
02/27/2002EP1181263A1 Treatment of a composition comprising a trimethylolalkane bis-monolinear formal
02/27/2002EP1181014A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
02/27/2002CN1337387A Method for preparing novel phenol compound divirated from dialkoxy acetaldehyde
02/26/2002US6350907 Matrix metalloprotease inhibitors
02/26/2002US6350902 Process for the selective N-formylation of N-hydroxylamines
02/26/2002US6350892 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
02/21/2002WO2002014302A1 Process for producing alkylene carbonate compound
02/21/2002WO2002014267A1 Novel aminocyclohexane derivatives
02/21/2002WO2002014265A1 Novel 3-substituted urea derivatives and medicinal use thereof
02/21/2002WO2002014259A1 Calcium receptor antagonists
02/21/2002US20020022752 Process for producing a fluorine containing compound by liquid phase fluorination
02/21/2002US20020020832 Photosensitive resin composition
02/21/2002DE10111224A1 Analoge der Ecstasy-Klasse sowie Verwendung derselben beim Nachweis von Verbindungen der Ecstasy-Klasse Analog ecstasy-class and use thereof in the detection of compounds of ecstasy-class
02/20/2002CN1336912A Novel propargylether derivatives
02/19/2002US6348618 Beta-ketoester compounds
02/19/2002US6348608 Catalytic asymmetric epoxidation
02/19/2002US6348606 Reacting a polyene diacetal with a cyclic dienol ether in presence of lewis acid
02/14/2002WO2002012224A2 Bicyclic compounds as h3 receptor ligands
02/14/2002WO2002012215A1 Process for the preparation of baccatin iii derivatives
02/14/2002WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/14/2002WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/14/2002WO2002012166A2 Triamine derivative melanocortin receptor ligands and methods of using same
02/14/2002WO2002011715A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
02/14/2002WO2001074910A3 Ether-amine based polymerization catalysts, compositions and processes using same
02/14/2002WO2001062711A3 Substituted alkylene diamine compounds
02/14/2002US20020019440 Aryloxypropanolamine derivatives, method of preparation and applications thereof
02/14/2002US20020019382 Curcumin analogs with anti-tumor and anti-angiogenic properties
02/14/2002US20020019380 1-(6-((dimethylamino)methyl)-1-methyl-2,3,5,6-tetrahydro-1H -cyclobuta(f)indol-6-yl)cyclohexanol, for example; treating psychological disorders such as depression, panic attacks, phobias, drug abuse, as well as obesity and bulemia
02/14/2002CA2419036A1 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/14/2002CA2419027A1 Bicyclic compounds as h3 receptor ligands
02/14/2002CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/14/2002CA2417098A1 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
02/13/2002EP1179520A1 Process for the preparation of phytone and novel intermediates thereof
02/13/2002EP1178958A2 N-cyanomethyl amides as protease inhibitors
02/13/2002EP1178792A1 Aryl amidines, compositions containing such compounds and methods of use
02/13/2002EP0873333B1 Phenyl benzyl ethers, process for producing them and their use as pesticide and fungicide
02/13/2002EP0699069B1 Endothelin receptor antagonists
02/12/2002US6346413 Polymer arrays
02/12/2002US6346242 Compounds and compositions for delivering active agents
02/12/2002CA2057504C Process for preparing new n-acyl-2,3-benzodiazepine derivatives, their acid addition salts and pharmaceutical compositions containing the same
02/07/2002WO2002010150A1 2,2-disubstituted 1,3-dioxolanes as antitussive agents
02/07/2002WO2002010149A1 1,3-dioxolanes with antitussive activity
02/07/2002WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/07/2002WO2002010096A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
02/07/2002WO2002009688A1 Fatty acid synthase inhibitors
02/07/2002WO2001062744A3 Substituted piperazine compounds
02/07/2002WO2001000566A3 Substituted phenoxyacetic acids
02/07/2002US20020016479 Heliotropin oxidized with a percarboxylic acid in the presence of formic acid; by-product inhibition
02/07/2002US20020016464 Sodium channel blockers used to treat amyotrophic lateral sclerosis; analgesics, anticonvulsants, antidepressants, local anesthetics and antiarrhythmics
02/07/2002US20020016463 Partial fatty acid oxidation inhibitors; protect skeletal muscles against damage resulting from trauma or systemic diseases, treat shock conditions, preserve donor tissue and organs used in transplants
02/07/2002US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc.
02/07/2002US20020016361 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
02/07/2002US20020016322 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use
02/07/2002CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/07/2002CA2416303A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
02/06/2002EP1178039A1 Derivatives of phenyl(thio)urea and phenyl(thio)carbamate fungicides
02/06/2002EP1177792A2 Dopamine D4 Ligands for the treatment of novelty-seeking disorders
02/06/2002EP1177197A2 Polyamines and their use in therapy
02/06/2002EP1177183A1 Hydroxamic and carboxylic acid derivatives
02/06/2002EP1177169A1 6- [(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof
02/06/2002EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
02/06/2002EP0771198B1 Dihydro-2,3-benzodiazepine derivatives
02/06/2002CN1334798A Phenylglycine derivatives
02/05/2002US6344570 Substituted urea derivatives as cell adhesion inhibitors
02/05/2002US6344561 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
02/05/2002US6344485 Method for treating glaucoma
02/05/2002CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists
01/2002
01/31/2002WO2001070682A3 Carbocyclic side chain containing metalloprotease inhibitors
01/31/2002WO2001014328A3 Substituted ureas as cell adhesion inhibitors
01/31/2002US20020013497 Alkylation, blocking
01/31/2002US20020013477 Synthesis of alkylene carbonates using a catalyst system comprising metal halide and pyridine or pyridine derivative
01/30/2002EP1175398A1 Indoline derivatives as progesterone antagonists
01/30/2002EP1175383A1 Glucocorticoid receptor modulators
01/30/2002EP1175382A1 Method for the dihydroxylation of olefins using transition-metal catalysts
01/30/2002EP1175379A1 Method for the asymmetric dihydroxylation of olefins, using osmium catalysts
01/30/2002EP0907634B1 Pesticides
01/30/2002CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
01/29/2002US6342613 Process for the synthesis of 5-(α-hydroxyalkyl) benzo[1,3]dioxols